Material: Gliclazide 80 mg. Tablets and 30 mg XR Tablet.
Instructions: Type II diabetes mellitus.
Dimensions and Usage Rules: 40-80 mg daily. If needed, gradually increase the level of 320 mg daily Until diabetes comes in control until it can be extended. Gicleade 30-120 mg for X-ray Tablet Seva once a day as per need. X-ray tablets should not be broken or crushed. It should be eaten with Nasta in the morning.
Warnings and in which cases can not be used: In cases of severe diabetes, surgical, wound and infection patients, in diabetic pre-comma and abdominal and severe acupuncture of kidney and liver by juvenile onset diabetes, ketosis and acidsosis.
Side effect: Hypoglycemia may occur in certain conditions. Nausea, appetite depression, diarrhea and constipation, eritema, leucopenia, thrombocytopenia, agranulosi- toosis, pansytopenia, hemolytic anemia, cholestatic joints and hemorrhage in the digestive system etc.
Reactions with other drugs: phenylbutazine, sulfonamide, comerine derivative, beta-blocker, tetracycline, clorromphycle, cofiberate, cementidine, microgenzial, barbiturate, corticosteroid, thyageide diuretic, thyroid hormone, lactative and oral contraceptives.
Use during pregnancy and breastfeeding: Should not be used for mothers during pregnancy and breastfeeding.
āĻāĻĒাāĻĻাāύ : āĻ্āϞিāĻাāĻাāĻāĻĄ ā§Žā§Ļ āĻŽি.āĻ্āϰা. āĻ্āϝাāĻŦāϞেāĻ āĻāĻŦং ā§Šā§Ļ āĻŽি.āĻ্āϰা. āĻāĻ্āϏ āĻāϰ āĻ্āϝাāĻŦāϞেāĻ।
āύিāϰ্āĻĻেāĻļāύা : āĻাāĻāĻĒ-⧍ āĻĄাāϝ়াāĻŦেāĻিāϏ āĻŽেāϞিāĻাāϏ।
āĻŽাāϤ্āϰা āĻ āĻŦ্āϝāĻŦāĻšাāϰ āĻŦিāϧি : āĻĻৈāύিāĻ ā§Ēā§Ļ-ā§Žā§Ļ āĻŽি.āĻ্āϰা.। āĻĒ্āϰāϝ়োāĻāύে āϧীāϰে āϧীāϰে āĻŽাāϤ্āϰা āĻĻৈāύিāĻ ā§Šā§¨ā§Ļ āĻŽি.āĻ্āϰা. āĻĒāϰ্āϝāύ্āϤ āĻŦৃāĻĻ্āϧি āĻāϰা āϝেāϤে āĻĒাāϰে āϝāϤāĻĻিāύ āύা āĻĄাāϝ়াāĻŦেāĻিāϏ āύিāϝ়āύ্āϤ্āϰāĻŖে āĻāϏে। āĻāĻ্āϏ āĻāϰ āĻ্āϝাāĻŦāϞেāĻেāϰ āĻ্āώেāϤ্āϰে āĻিāĻাāĻাāĻāĻĄ ā§Šā§Ļ-⧧⧍ā§Ļ āĻŽি.āĻ্āϰা. āĻĒ্āϰāϝ়োāĻāύ āĻ āύুāϝাāϝ়ী āĻĻিāύে āĻāĻāĻŦাāϰ āϏেāĻŦ্āϝ। āĻāĻ্āϏ āĻāϰ āĻ্āϝাāĻŦāϞেāĻ āĻেāĻ্āĻে āĻŦা āĻুāώে āĻাāĻāϝ়া āĻāĻিāϤ āύāϝ়। āϏāĻাāϞে āύাāϏāϤ্āĻŽাāϰ āϏাāĻĨে āĻাāĻāϝ়া āĻāĻিāϤ।
āϏāϤāϰ্āĻāϤা āĻ āϝেāϏāĻŦ āĻ্āώেāϤ্āϰে āĻŦ্āϝāĻŦāĻšাāϰ āĻāϰা āϝাāĻŦে āύা : āĻুāĻেāύাāĻāϞ āĻ āύāϏেāĻ āĻĄাāϝ়াāĻŦেāĻিāϏে, āĻিāĻোāϏিāϏ্ āĻāĻŦং āĻāϏিāĻĄোāϏিāϏ্ āĻĻ্āĻŦাāϰা āĻāĻিāϞ āĻĄাāϝ়াāĻŦেāĻিāϏে, āĻ āϏ্āϤ্āϰোāĻĒāĻাāϰ, āĻ্āώāϤ āĻāĻŦং āϏংāĻ্āϰāĻŽāĻŖেāϰ āϰোāĻীāĻĻেāϰ āĻ্āώেāϤ্āϰে, āĻĄাāϝ়াāĻŦেāĻিāĻ āĻĒ্āϰি-āĻāĻŽা āĻāĻŦং āĻāĻŽাāϰ āĻ্āώেāϤ্āϰে āĻāĻŦং āĻŦৃāĻ্āĻ āĻ āϝāĻৃāϤেāϰ āϤীāĻŦ্āϰ āĻ āĻĒāϰ্āϝাāĻĒ্āϤāϤাāϝ়।
āĻĒাāϰ্āĻļ্āĻŦ āĻĒ্āϰāϤিāĻ্āϰিāϝ়া : āĻিāĻু āĻিāĻু āĻŦিāĻļেāώ āĻ āĻŦāϏ্āĻĨাāϝ় āĻšাāĻāĻĒোāĻ্āϞাāĻāϏেāĻŽিāϝ়া āĻšāϤে āĻĒাāϰে। āĻŦāĻŽি āĻŦāĻŽি āĻাāĻŦ,āĻ্āώুāϧা āĻŽāύ্āĻĻা, āĻĄাāϝ়āϰিāϝ়া āĻāĻŦং āĻোāώ্āĻ āĻাāĻ িāύ্āϝ, āĻāϰিāĻĨেāĻŽা, āϞিāĻāĻোāĻĒেāύিāϝ়া, āĻĨ্āϰāĻŽ্āĻŦোāϏাāĻāĻোāĻĒেāύিāϝ়া, āĻāĻ্āϰাāύুāϞোāϏাāĻ- āĻোāϏিāϏ, āĻĒ্āϝাāύāϏাāĻāĻোāĻĒেāύিāϝ়া, āĻšিāĻŽোāϞাāĻāĻিāĻ āĻāύেāĻŽিāϝ়া, āĻোāϞেāϏ্āĻ্āϝাāĻিāĻ āĻāĻŖ্āĻĄিāϏ āĻāĻŦং āĻĒāϰিāĻĒাāĻāύাāϞীāϰ āĻšেāĻŽোāϰেāĻ āĻāϤ্āϝাāĻĻি।
āĻ āύ্āϝ āĻāώুāϧেāϰ āϏাāĻĨে āĻĒ্āϰāϤিāĻ্āϰিāϝ়া : āĻĢিāύাāĻāϞāĻŦিāĻāĻাāĻোāύ, āϏাāϞāĻĢোāύাāĻŽাāĻāĻĄ, āĻোāĻŽাāϰিāύ āĻĄেāϰিāĻেāĻিāĻ, āĻŦিāĻা- āĻŦ্āϞāĻাāϰ, āĻেāĻ্āϰাāϏাāĻāĻ্āϞিāύ, āĻ্āϞোāϰাāĻŽāĻĢেāύিāĻāϞ, āĻোāĻĢাāĻāĻŦ্āϰেāĻ, āϏিāĻŽেāĻিāĻĄিāύ, āĻŽাāĻāĻোāύাāĻāϞ, āĻŦাāϰāĻŦিāĻুāϰেāĻ, āĻāϰ্āĻিāĻোāώ্āĻেāϰāϝ়েāĻĄ, āĻĨাāϝ়াāĻাāĻāĻĄ āĻĄাāĻāĻāĻāϰেāĻিāĻ, āĻĨাāĻāϰāϝ়েāĻĄ āĻšāϰāĻŽোāύ, āϞ্āϝাāĻ্āϏাāĻিāĻ āĻāĻŦং āĻŽুāĻে āϏেāĻŦ্āϝ āĻāύ্āĻŽāύিāϰোāϧāĻ āϏāĻŽূāĻš।
āĻāϰ্āĻাāĻŦāϏ্āĻĨা āĻ āϏ্āϤāύ্āϝāĻĻাāύāĻাāϞে āĻŦ্āϝāĻŦāĻšাāϰ : āĻāϰ্āĻাāĻŦāϏ্āĻĨাāϝ় āĻ āϏ্āϤāύ্āϝāĻĻাāύāĻাāϞীāύ āĻŽাāϝ়েāĻĻেāϰ āĻ্āώেāϤ্āϰে āĻŦ্āϝāĻŦāĻšাāϰ āĻāϰা āĻāĻিāϤ āύāϝ়।
Instructions: Type II diabetes mellitus.
Dimensions and Usage Rules: 40-80 mg daily. If needed, gradually increase the level of 320 mg daily Until diabetes comes in control until it can be extended. Gicleade 30-120 mg for X-ray Tablet Seva once a day as per need. X-ray tablets should not be broken or crushed. It should be eaten with Nasta in the morning.
Warnings and in which cases can not be used: In cases of severe diabetes, surgical, wound and infection patients, in diabetic pre-comma and abdominal and severe acupuncture of kidney and liver by juvenile onset diabetes, ketosis and acidsosis.
Side effect: Hypoglycemia may occur in certain conditions. Nausea, appetite depression, diarrhea and constipation, eritema, leucopenia, thrombocytopenia, agranulosi- toosis, pansytopenia, hemolytic anemia, cholestatic joints and hemorrhage in the digestive system etc.
Reactions with other drugs: phenylbutazine, sulfonamide, comerine derivative, beta-blocker, tetracycline, clorromphycle, cofiberate, cementidine, microgenzial, barbiturate, corticosteroid, thyageide diuretic, thyroid hormone, lactative and oral contraceptives.
Use during pregnancy and breastfeeding: Should not be used for mothers during pregnancy and breastfeeding.
āĻāĻĒাāĻĻাāύ : āĻ্āϞিāĻাāĻাāĻāĻĄ ā§Žā§Ļ āĻŽি.āĻ্āϰা. āĻ্āϝাāĻŦāϞেāĻ āĻāĻŦং ā§Šā§Ļ āĻŽি.āĻ্āϰা. āĻāĻ্āϏ āĻāϰ āĻ্āϝাāĻŦāϞেāĻ।
āύিāϰ্āĻĻেāĻļāύা : āĻাāĻāĻĒ-⧍ āĻĄাāϝ়াāĻŦেāĻিāϏ āĻŽেāϞিāĻাāϏ।
āĻŽাāϤ্āϰা āĻ āĻŦ্āϝāĻŦāĻšাāϰ āĻŦিāϧি : āĻĻৈāύিāĻ ā§Ēā§Ļ-ā§Žā§Ļ āĻŽি.āĻ্āϰা.। āĻĒ্āϰāϝ়োāĻāύে āϧীāϰে āϧীāϰে āĻŽাāϤ্āϰা āĻĻৈāύিāĻ ā§Šā§¨ā§Ļ āĻŽি.āĻ্āϰা. āĻĒāϰ্āϝāύ্āϤ āĻŦৃāĻĻ্āϧি āĻāϰা āϝেāϤে āĻĒাāϰে āϝāϤāĻĻিāύ āύা āĻĄাāϝ়াāĻŦেāĻিāϏ āύিāϝ়āύ্āϤ্āϰāĻŖে āĻāϏে। āĻāĻ্āϏ āĻāϰ āĻ্āϝাāĻŦāϞেāĻেāϰ āĻ্āώেāϤ্āϰে āĻিāĻাāĻাāĻāĻĄ ā§Šā§Ļ-⧧⧍ā§Ļ āĻŽি.āĻ্āϰা. āĻĒ্āϰāϝ়োāĻāύ āĻ āύুāϝাāϝ়ী āĻĻিāύে āĻāĻāĻŦাāϰ āϏেāĻŦ্āϝ। āĻāĻ্āϏ āĻāϰ āĻ্āϝাāĻŦāϞেāĻ āĻেāĻ্āĻে āĻŦা āĻুāώে āĻাāĻāϝ়া āĻāĻিāϤ āύāϝ়। āϏāĻাāϞে āύাāϏāϤ্āĻŽাāϰ āϏাāĻĨে āĻাāĻāϝ়া āĻāĻিāϤ।
āϏāϤāϰ্āĻāϤা āĻ āϝেāϏāĻŦ āĻ্āώেāϤ্āϰে āĻŦ্āϝāĻŦāĻšাāϰ āĻāϰা āϝাāĻŦে āύা : āĻুāĻেāύাāĻāϞ āĻ āύāϏেāĻ āĻĄাāϝ়াāĻŦেāĻিāϏে, āĻিāĻোāϏিāϏ্ āĻāĻŦং āĻāϏিāĻĄোāϏিāϏ্ āĻĻ্āĻŦাāϰা āĻāĻিāϞ āĻĄাāϝ়াāĻŦেāĻিāϏে, āĻ āϏ্āϤ্āϰোāĻĒāĻাāϰ, āĻ্āώāϤ āĻāĻŦং āϏংāĻ্āϰāĻŽāĻŖেāϰ āϰোāĻীāĻĻেāϰ āĻ্āώেāϤ্āϰে, āĻĄাāϝ়াāĻŦেāĻিāĻ āĻĒ্āϰি-āĻāĻŽা āĻāĻŦং āĻāĻŽাāϰ āĻ্āώেāϤ্āϰে āĻāĻŦং āĻŦৃāĻ্āĻ āĻ āϝāĻৃāϤেāϰ āϤীāĻŦ্āϰ āĻ āĻĒāϰ্āϝাāĻĒ্āϤāϤাāϝ়।
āĻĒাāϰ্āĻļ্āĻŦ āĻĒ্āϰāϤিāĻ্āϰিāϝ়া : āĻিāĻু āĻিāĻু āĻŦিāĻļেāώ āĻ āĻŦāϏ্āĻĨাāϝ় āĻšাāĻāĻĒোāĻ্āϞাāĻāϏেāĻŽিāϝ়া āĻšāϤে āĻĒাāϰে। āĻŦāĻŽি āĻŦāĻŽি āĻাāĻŦ,āĻ্āώুāϧা āĻŽāύ্āĻĻা, āĻĄাāϝ়āϰিāϝ়া āĻāĻŦং āĻোāώ্āĻ āĻাāĻ িāύ্āϝ, āĻāϰিāĻĨেāĻŽা, āϞিāĻāĻোāĻĒেāύিāϝ়া, āĻĨ্āϰāĻŽ্āĻŦোāϏাāĻāĻোāĻĒেāύিāϝ়া, āĻāĻ্āϰাāύুāϞোāϏাāĻ- āĻোāϏিāϏ, āĻĒ্āϝাāύāϏাāĻāĻোāĻĒেāύিāϝ়া, āĻšিāĻŽোāϞাāĻāĻিāĻ āĻāύেāĻŽিāϝ়া, āĻোāϞেāϏ্āĻ্āϝাāĻিāĻ āĻāĻŖ্āĻĄিāϏ āĻāĻŦং āĻĒāϰিāĻĒাāĻāύাāϞীāϰ āĻšেāĻŽোāϰেāĻ āĻāϤ্āϝাāĻĻি।
āĻ āύ্āϝ āĻāώুāϧেāϰ āϏাāĻĨে āĻĒ্āϰāϤিāĻ্āϰিāϝ়া : āĻĢিāύাāĻāϞāĻŦিāĻāĻাāĻোāύ, āϏাāϞāĻĢোāύাāĻŽাāĻāĻĄ, āĻোāĻŽাāϰিāύ āĻĄেāϰিāĻেāĻিāĻ, āĻŦিāĻা- āĻŦ্āϞāĻাāϰ, āĻেāĻ্āϰাāϏাāĻāĻ্āϞিāύ, āĻ্āϞোāϰাāĻŽāĻĢেāύিāĻāϞ, āĻোāĻĢাāĻāĻŦ্āϰেāĻ, āϏিāĻŽেāĻিāĻĄিāύ, āĻŽাāĻāĻোāύাāĻāϞ, āĻŦাāϰāĻŦিāĻুāϰেāĻ, āĻāϰ্āĻিāĻোāώ্āĻেāϰāϝ়েāĻĄ, āĻĨাāϝ়াāĻাāĻāĻĄ āĻĄাāĻāĻāĻāϰেāĻিāĻ, āĻĨাāĻāϰāϝ়েāĻĄ āĻšāϰāĻŽোāύ, āϞ্āϝাāĻ্āϏাāĻিāĻ āĻāĻŦং āĻŽুāĻে āϏেāĻŦ্āϝ āĻāύ্āĻŽāύিāϰোāϧāĻ āϏāĻŽূāĻš।
āĻāϰ্āĻাāĻŦāϏ্āĻĨা āĻ āϏ্āϤāύ্āϝāĻĻাāύāĻাāϞে āĻŦ্āϝāĻŦāĻšাāϰ : āĻāϰ্āĻাāĻŦāϏ্āĻĨাāϝ় āĻ āϏ্āϤāύ্āϝāĻĻাāύāĻাāϞীāύ āĻŽাāϝ়েāĻĻেāϰ āĻ্āώেāϤ্āϰে āĻŦ্āϝāĻŦāĻšাāϰ āĻāϰা āĻāĻিāϤ āύāϝ়।